Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.70    0.00 (0.00%)
Bid:
0.65
Ask:
0.75
Spread: 0.10 (15.385%)
Market Cap: £3.13m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Contract award announcement

23 Sep 2019 07:00

RNS Number : 1995N
Thruvision Group PLC
23 September 2019
 

 

RNS

23 September 2019

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Contract award announcement

 

Thruvision (AIM: THRU) the specialist provider of people-screening technology to the international security market, is pleased to announce a strategically important contract award by the US Government's Customs and Border Protection (CBP) totalling $3.0 million, of which $2.9 million will be delivered in FY20.

 

This latest award is in addition to winning a contract, valued at £0.4 million to supply a new Asian customs agency customer earlier in September.

 

Commenting on the award, Colin Evans, Chief Executive, said "We are delighted to add CBP as our eighth national customs agency customer. This award reinforces Thruvision's international standing as a first choice provider of safe and respectful people security screening technology as we continue to broaden our strategically important US Government customer base."

 

Interest in Thruvision's Customs contraband detection solution - which screens travellers for drugs, cash and other prohibited items at international border control points - continues to grow. During 2019 the Group has already delivered units to a broad range of national government agency customers, including UK Border Force, the Czech Republic, and a repeat order from Vietnam. Momentum has continued, and as previously announced, the Group received a first order from the US State Department's Bureau of International Narcotics and Law Enforcement Affairs, and a repeat order from Hong Kong Customs early during this financial year.

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 436180

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Bank plc +44 (0)20 7597 5970

Andrew Pinder / Sebastian Lawrence / Patrick Robb

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Shamma Kelly

 

 

About Thruvision

Thruvision is the leading provider of next-generation people-screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing, at distances up to 10m.

Addressing the growing need for fast, safe and effective security, Thruvision has been vetted and approved by the US Transportation Security Administration for surface transportation. More than 250 units have now been deployed in 21 countries worldwide over the last five years for applications including mass transit and aviation security, facilities and public area protection, customs and border control and supply chain loss prevention. Thruvision has offices near Oxford and in Washington DC.

 

www.thruvision.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTMMGZLVZZGLZM
Date   Source Headline
30th Sep 20133:26 pmRNSVoting Rights and Capital
27th Sep 20131:31 pmRNSHolding(s) in Company
25th Sep 20137:00 amRNSContract Announcements
17th Sep 201310:04 amRNSAnnual Report and Accounts
21st Aug 20132:13 pmRNSBlocklisting application
6th Aug 20137:00 amRNSContract Announcement
30th Jul 201310:39 amRNSHolding(s) in Company
23rd Jul 20137:00 amRNSContract Announcement
22nd Jul 20132:40 pmRNSResult of AGM
8th Jul 20134:21 pmRNSDirectorate Change
29th May 20137:00 amRNSFinal Results
24th May 20139:00 amRNSNotice of Preliminary Results
13th May 20133:19 pmRNSHolding(s) in Company
1st May 20137:00 amRNSAppointment
29th Apr 20133:53 pmRNSHolding(s) in Company
23rd Apr 20138:18 amRNSHolding(s) in Company
22nd Apr 201311:35 amRNSHolding(s) in Company
19th Apr 20132:56 pmRNSHolding(s) in Company
2nd Apr 20137:02 amRNSSingTel VSaaS Agreement
2nd Apr 20137:01 amRNSUK Contract Award
2nd Apr 20137:00 amRNSTrading Update
22nd Feb 201312:00 pmRNSDirector/PDMR Shareholding
18th Feb 20132:14 pmRNSDirector/PDMR Shareholding
7th Jan 20137:00 amRNSAcquisition of Visimetrics (UK) Limited
4th Jan 201310:44 amRNSHolding(s) in Company
4th Jan 20137:00 amRNSContract awards
3rd Jan 20131:53 pmRNSHolding(s) in Company
2nd Jan 20133:03 pmRNSDirectors Dealings
2nd Jan 20132:57 pmRNSHolding(s) in Company
27th Dec 201210:24 amRNSResult of General Meeting
7th Dec 20122:44 pmRNSHolding(s) in Company
6th Dec 20127:00 amRNSProposed £10m Placing and Share Schemes Amendments
29th Nov 20127:00 amRNSContract Awards
22nd Nov 20127:00 amRNSInterim Results
19th Nov 20127:00 amRNSNotice of Results
14th Nov 20125:57 pmRNSHolding(s) in Company
6th Nov 20123:17 pmRNSHolding(s) in Company
5th Nov 201212:21 pmRNSHolding(s) in Company
1st Nov 20122:36 pmRNSHolding(s) in Company
18th Oct 20127:00 amRNSBoard Appointment
13th Sep 20127:00 amRNSRe: Appointment
11th Sep 20125:24 pmRNSHolding(s) in Company
11th Sep 20125:24 pmRNSHolding(s) in Company
25th Jul 20122:46 pmRNSResult of AGM
29th Jun 20125:16 pmRNSHolding(s) in Company
25th Jun 20127:00 amRNSBoard Change
8th Jun 20127:00 amRNSLong Term Incentive Plan Grant
29th May 20127:00 amRNSPreliminary Results
25th May 20127:00 amRNSNotice of Results
3rd May 20127:00 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.